noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

AstraZeneca Pharmaceuticals LP

BREZTRI approved in the US for asthma as first and only triple therapy[...]
Ambiq Micro Inc.

Ambiq Micro to Report First Quarter 2026 Financial Results
Ocugen Inc.

Additional Proxy Soliciting Materials (Form DEFA14A)

Technology

On Holding AG

04/28/2026 | Press release | Distributed by Public on 04/28/2026 03:46

Impact progress report 2025

On Holding AG published this content on April 28, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 28, 2026 at 09:46 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]